California Governor Gavin Newsom Signs Senate Bill 1023 For HIV Prevention
Governor Gavin Newsom signed Senate Bill 1023, requiring health plans to cover long-acting injectable HIV pre-exposure prophylaxis through outpatient prescription benefits.
Practical wellness advice, breakthrough studies and public-health alerts explained by medical professionals.
Governor Gavin Newsom signed Senate Bill 1023, requiring health plans to cover long-acting injectable HIV pre-exposure prophylaxis through outpatient prescription benefits.
A large North American clinical trial published in Nature Medicine reveals that combining GRAIL’s Galleri multi-cancer early detection blood test with routine screenings increased…
Researchers tracked nearly 3.7 million births over three decades in a Swedish study published in JAMA Pediatrics showing children born with rare congenital infections known as…
Consuming sugary foods while taking antibiotics significantly worsens gut microbiome disruption, according to a study published on September 30, 2026, in Nature.
A study published in the British Journal of Sports Medicine finds that walking more or walking faster reduces early death risk, with 7,500–10,000 steps daily at a peak pace of…
A study published in Nature found that consuming sugar-rich foods during antibiotic treatment worsens gut microbiome disruption, with an additional 21% reduction in bacterial…
A 2026 study presented at the 42nd International Marketing Association Congress highlights the disconnect between consumer intent to eat healthily and actual choices, revealing…
Pennsylvania health officials reported the state’s fifth measles-associated death on Wednesday, involving an unvaccinated Lancaster County resident, as the United States navigates…
Popular GLP-1 weight-loss medications like Ozempic and Wegovy can trigger rapid weight loss and severe caloric restriction, raising concerns among medical experts that extreme…
Ukraine has officially launched its influenza and acute respiratory viral infection epidemic season, set to run through May 23, 2027.
Even when antiretroviral medications successfully suppress HIV replication, about 40 percent of patients continue to experience neurological complications.
Merck is halting U.S. production and distribution of Recarbrio, a specialized antibacterial combination drug designed to treat severe hospital-acquired infections and multidrug-resistant pathogens. The abrupt withdrawal…